Skip to content

Evaluation of the Efficacy, Safety, and Patient Self-Assessment in Reducing Downtime by Use of Membrane Formation Collagen Hydrogel Following Ablative CO2 Fractional Laser Resurfacing

Evaluation of the Efficacy, Safety, and Patient Self-Assessment in Reducing Downtime by Use of Membrane Formation Collagen Hydrogel Following Ablative CO2 Fractional Laser Resurfacing

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-jRCT1070250117
Enrollment
5
Registered
2025-12-19
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A, healthy people. N/A

Interventions

Same subject, the treatment area is on their face. Intervention-side: The left side of the treatment area is subjected to membrane formation collagen hydrogel after treatment. Control side: The right

Sponsors

Utako Kimura
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy Asian people aged 20~60. Skin type: 3-4 Someone is available in this study's schedule. Someone who is less revealed in sunlight during the observational period. Someone who can accept researchers' orders.

Exclusion criteria

Exclusion criteria: Someone who has received the facial treatment for aesthetic purposes within 90 days before this study. Chemical Sensitivity, especially alcoholic sensitivity. Someone subject to the contraindication of Ablative CO2 Fractional Laser Resurfacing. Someone whom the researcher considers not appropriate for this study.

Design outcomes

Primary

MeasureTime frame
1. Statistical analysis of red images acquired by an imaging device 2. Statistical significance of differences between left and right sides in the mean stratum corneum moisture content and TEWL values for all subjects post-treatment.

Secondary

MeasureTime frame
1. Presence of adverse events (AE) items 7 days and 14 days after treatment by the physician. AE items: Erythema, Edema, Pinpoint Bleeding, Oozing, Crusting 2 Subject self-assessment in the use of both products, questionnaire survey of subjects from 1 to 3 days after treatment

Contacts

Public ContactKimura Utako

Dr.Spa Clinic

utako@juntendo.ac.jp+81-120-022-118

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026